We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
-3.38%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$934M
AUM Growth
+$29.8M
(+3.3%)
Cap. Flow
+$64.1M
Cap. Flow
% of AUM
6.87%
Top 10 Holdings %
Top 10 Hldgs %
51.09%
Holding
212
New
29
Increased
119
Reduced
37
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.96M |
| 2 |
Schwab International Equity ETF
SCHF
|
+$7.17M |
| 3 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$6.78M |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$5.19M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.85M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.57M |
| 3 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$1.29M |
| 4 |
Home BancShares
HOMB
|
+$1.14M |
| 5 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$890K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.03% |
| 2 | Technology | 4.37% |
| 3 | Healthcare | 1.15% |
| 4 | Financials | 1.02% |
| 5 | Communication Services | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRXH
201
SRX Global
SRXH
$34.7M
| $30.2K | ﹤0.01% |
124
+51
| +70% | +$19.6K |
|
202
Lloyds Banking Group
LYG
$85.7B
| $24.3K | ﹤0.01% |
+11,391
| New | +$24.7K |
|
203
ImmunityBio
IBRX
$8.53B
| $17.8K | ﹤0.01% |
+10,555
| New | +$21.2K |
|
|
EFTR
204
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $12K | ﹤0.01% |
800
| – | – |
|
|
205
Vanguard Short-Term Bond ETF
BSV
$45.6B
| – | – |
-20,760
| Closed | -$1.57M |
|
|
AGNT
206
AGNT Inc
AGNT
$709M
| – | – |
-10,568
| Closed | -$214K |
|
207
IQVIA
IQV
$43.1B
| – | – |
-1,150
| Closed | -$258K |
|
208
Cohen & Steers Duration Preferred & Income Fund
LDP
$601M
| – | – |
-10,000
| Closed | -$182K |
|
209
Royal Caribbean
RCL
$74.7B
| – | – |
-2,100
| Closed | -$218K |
|
210
iShares 20+ Year Treasury Bond ETF
TLT
$46.8B
| – | – |
-4,633
| Closed | -$477K |
|
|
211
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
| – | – |
-24,472
| Closed | -$1.85M |
|
|
INFI
212
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| – | – |
-158,500
| Closed | -$33.4K |
|
Similar funds
MBA
SIA
AP
MW
SBIA
LC
TW
PAME
Callan Capital's Q3 2023 Portfolio in Review
As of Q3 2023, Callan Capital held 212 positions worth $934M, up 3.3% from $904M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Callan Capital deployed $64.1M of net new capital in Q3 2023, opening 29 new positions and adding to 119 existing holdings. Its largest new stake was Fortinet: 52,261 shares worth $3.07M.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 91% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, an estimated $1.29M trimmed.
- Callan Capital's largest Q3 2023 buy was Fortinet: 52,261 shares worth $3.07M.
- Callan Capital added most to Schwab Fundamental US Large Company Index ETF in Q3 2023, an estimated $8.96M increase.
- Callan Capital's biggest Q3 2023 reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, cutting an estimated $1.29M.
- Callan Capital fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2023, selling an estimated $1.85M.
- Callan Capital's ten largest holdings make up 51% of its $934M portfolio in Q3 2023.
- Callan Capital opened 29 new positions and closed 8 in Q3 2023.
- Callan Capital's portfolio value rose 3.3% quarter-over-quarter to $934M.
Based on Callan Capital's 13F filing for Q3 2023, filed 6 Nov 2023.